pharmacology of CV system Flashcards

1
Q

antihypertensive drugs

A

diuretics

sympatholytic drugs

vasodilators

inhibition of the renin-angiotensin system

calcium channel blockers

treatment of hyperlipidemia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

diuretics

A

increase the formation and excretion of urine to decrease plasma fluid volume

thiazide diuretics

loop diuretics

potassium-sparing diuretics

adverse effects

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

thiazide diuretics

A

act on the early portion of the distal tubule of the nephron

inhibit sodium reabsorption

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

loop diuretics

A

act primarily on the ascending limb of the loop of henle

inhibit the reabsorption of sodium and chloride from the nephron

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

potassium-sparing diretics

A

prevent the secretion of potassium into the distal tubule

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

adverse effects of diuretics

A

fluid depletion and electrolyte imbalance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

sympatholytic drugs

A

decrease sympathetic influence on the heart and/or peripheral vasculature

beta blockers

alpha blockers

presynaptic adrenergic inhibitors

centrally acting agents

ganglionic blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

beta blockers

A

slow HR

reduce CO

produce general decrease in sympathetic tone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

alpha blockers

A

decrease vascular resistance in vascular smooth muscle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

presynaptic adrenergic inhibitors

A

depletion of norepinephrine from the presynaptic terminal decreases sympathetic-mediated excitation of the heart and peripheral vasculature

resulting in decreased BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

centrally acting agents

A

limit sympathetic activity at the brainstem vasomotor center

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ganglionic blockers

A

block synaptic transmission at autonomic ganglia

decreasing systemic sympathetic activity

reducing BP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

vasodilators

A

decreases peripheral vascular resistance

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

inhibition of renin-angiotensin system

A

angiotensin converting enzyme (ACE) inhibitors

angiotensin II blockers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ACE inhibitors

A

decrease the hypertensive effects of angiotensin II by limiting the production of angiotensin II

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

angiotensin II blockers

A

block receptor for angiotensin II

blocking effects

17
Q

calcium channel blockers

A

limit calcium entry into vascular smooth muscle and cardiac muscle

decrease vascular smooth muscle contraction and myocardial force and rate of contraction

18
Q

treatment of hyperlipidemia

A

focus on reducing atherogenic lipoproteins and increasing the beneficial HDLs

HMG-CoA reductase inhibitors (statins)

19
Q

statins

A

decrease cholesterol production, especially in liver cells

lipitor

20
Q

antithrombotic drugs

A

inhibit the function of platelets

aspirin

others reduce platelet-induced clotting

adverse effects –> increased risk of bleeding

21
Q

aspirin

A

suppresses platelet aggregation by inhibiting the synthesis of prostaglandins and thromboxanes

22
Q

thrombolytic drugs

A

facilitate the breakdown and dissolution of clots that have already formed

streptokinase and urokinase

anistreplase

reteplase and tenecteplase

adverse effects

23
Q

streptokinase and urokinase

A

bring about the activation of plasmin, can be used to successfully resolve acute clot formation in coronary arteries and peripheral vessels

24
Q

anistreplase

A

binds to fibrin, where it is chemically activated so that the streptokinase can modify plasminogen and initiate clot breakdown

25
Q

reteplase and tenecteplase

A

newer agents

can be given more rapidly

further studies need to be done

26
Q

adverse effects

A

hemorrhage

excessive bleeding

fever

allergic reaction